Harbour BioMed's Series B Round

Harbour BioMed raised a round of funding on August 27, 2018.

Harbour BioMed (和铂医药) is a global biotechnology company discovering and developing therapeutics for cancer with a focus on immuno-oncology.…

Articles about Harbour BioMed's Series B Round: